The findings could potentially lead to new therapies and could stop the growth of cancers
The findings could potentially lead to new therapies and could stop the growth of cancers
Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications
The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide
The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda
The inherited disorder is caused by genetic mutations that affects haemoglobin production
Bacteroides fragilis in the gut improves immunity and immunotherapy treatment responses
The progressive neurological condition affects more than six million people worldwide
Bladder cancer, including papillary tumours, is the ninth most common cancer type worldwide
GPT-4 is trained on datasets to offer eye-related advice, diagnosis and management suggestions
An estimated 50% of human genes follow a circadian cycle, many of which are active in the liver
The method has the potential to be used to deliver RNA to the bloodstream for a range of diseases
The new process makes generating active pharmaceutical ingredients quicker and easier
The new method could help to prevent severe side effects caused by enantiomer drugs